Original language | English (US) |
---|---|
Pages (from-to) | 257-259 |
Number of pages | 3 |
Journal | JAMA neurology |
Volume | 77 |
Issue number | 2 |
DOIs | |
State | Published - Feb 2020 |
ASJC Scopus subject areas
- Clinical Neurology
Access to Document
Other files and links
Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
In: JAMA neurology, Vol. 77, No. 2, 02.2020, p. 257-259.
Research output: Contribution to journal › Letter › peer-review
}
TY - JOUR
T1 - Coexistence of Myelin Oligodendrocyte Glycoprotein and Aquaporin-4 Antibodies in Adult and Pediatric Patients
AU - Kunchok, Amy
AU - Chen, John J.
AU - McKeon, Andrew
AU - Mills, John R.
AU - Flanagan, Eoin P.
AU - Pittock, Sean J.
N1 - Funding Information: Conflict of Interest Disclosures: Dr Kunchok has received research funding from Biogen. Dr McKeon has received research funding from Alexion, Grifols, and Medimmune and reported grants from Euroimmun outside the submitted work. Dr Flanagan is a site principal investigator in a randomized placebo-controlled clinical trial of inebilizumab (a CD-19 inhibitor) in neuromyelitis optica spectrum disorders funded by MedImmune/Viela Bio and has served on that organization’s advisory board. Dr Pittock reports grants, personal fees, and nonfinancial support from Alexion Pharmaceuticals Inc and Guthy Jackson Charitable Foundation; consulting fees from Euroimmun; grants from Grifols, the National Institutes of Health (grant RO1 NS065829-01), and Autoimmune Encephalitis Alliance; grants, personal fees, nonfinancial support, and honoraria from MedImmune Inc; and a patent (#9,891,219; application #12-573942). Drs Pittock and McKeon have patents pending for various IgG as biomarkers of autoimmune neurological disorders (septin-5, Kelch-like protein 11, glial fibrillary acidic protein, phosphodiesterase 10A, and microtubule‐associated protein 1B). No other disclosures were reported. Additional Contributions: We would like to acknowledge the Mayo Clinic Neuroimmunology Laboratory research administrative and laboratory staff: James Fryer, myelin oligodendrocyte glycoprotein–IgG flow cytometry assay testing and development, Thomas Hartman, MBA, laboratory manager, Jade Zbacnik, laboratory specialist, Jessica Sagen, MA, research coordinator, and Mary Curtis, laboratory secretary. Compensation was as per normal employment practices only.
PY - 2020/2
Y1 - 2020/2
UR - http://www.scopus.com/inward/record.url?scp=85074267617&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85074267617&partnerID=8YFLogxK
U2 - 10.1001/jamaneurol.2019.3656
DO - 10.1001/jamaneurol.2019.3656
M3 - Letter
C2 - 31657826
AN - SCOPUS:85074267617
SN - 2168-6149
VL - 77
SP - 257
EP - 259
JO - JAMA neurology
JF - JAMA neurology
IS - 2
ER -